Andreas Persidis

[Andreas Persidis @AndreasPersidis]

The promise and tragedy of "out of context" https://t.co/R55pv6zHpb

[Andreas Persidis @AndreasPersidis]

@ylecun @demishassabis I agree it's a question of definitions. And as AI gets democratised, we'll increasingly face the challenge of agreeing on common vocabularies. I also predict that we'll soon have to redefine what a definition is in view of how AI systems represent concepts
https://t.co/0JfQOFO7ud

[Andreas Persidis @AndreasPersidis]

Happy to have started a substack where I now post my thoughts on AI related developments. Here it is:
https://t.co/Jbc4hgYBp5
Feel free to subscribe - its free :-)

[Andreas Persidis @AndreasPersidis]

@BiovistaInc @quantum very excited about this promising combination of technologies to make target discovery more efficient!

[Biovista Inc. @BiovistaInc]

@ArisPersidis will speak at the Annual Drug Repositioning, Repurposing and Rescue Conference https://t.co/HWoM6xNUnh

[Andreas Persidis @AndreasPersidis]

New opinion paper on the need to "reposition drug safety" and make the drug approval #regulatory framework more "ADR friendly" https://t.co/c59LzZg8T1

[Andreas Persidis @AndreasPersidis]

According to #FT a trend from #CES2020 is that #BigData trumps #privacy . If so, the #healthcare industry needs to take a clear stance AND steps to protect #patients interests and ensure fair competition. https://t.co/i3U5P3Djhj

[Andreas Persidis @AndreasPersidis]

This 13-year-old scientist invented a safer way to treat pancreatic cancer, and he hasn't even started high school yet https://t.co/JhAWeGhQ9f via @businessinsider

[Biovista Inc. @BiovistaInc]

Biovista President Aris Persidis talks today on how #artificial_intelligence driven #drugrepurposing can impact key aspects of #healthcare relevant to the discovery and development of drugs at the #AI Innovations For #lifesciences Summit West https://t.co/SJVczUcxz1

[Andreas Persidis @AndreasPersidis]

The increasing importance of predicting adverse events & the role of Augmented Intelligence.
Case in point: precision medicine and drug repurposing https://t.co/tAoytMfNn4

[Andreas Persidis @AndreasPersidis]

China’s children are its secret weapon in the global AI arms race https://t.co/iahM2CzesW

[Andreas Persidis @AndreasPersidis]

"Data is not the new oil" the article discusses how value is created and sustained only through the right combination of data - with specific attributes - and software

https://t.co/LJD2ElvcLE

[Andreas Persidis @AndreasPersidis]

@BiovistaInc & @HPE_HPC work with Sarah Bush Lincoln Health Center to advance #patientsafety & #personalizedmedicine treatments in #Cancer https://t.co/aWX5hvsEhU

[Bill Mannel @Bill_Mannel]

. @BiovistaInc and @HPE_HPC join forces to advance personalized medicine: https://t.co/TDddcU0328 #AI and #BigDataAnalytics

[Biovista Inc. @BiovistaInc]

Graham Anthony of @BiovistaInc presents at the #HPC User Forum Milwaukee https://t.co/NooWnYmxCl

[Andreas Persidis @AndreasPersidis]

These light-eating bacteria could one day help us survive heart attacks https://t.co/WHXFfR7eV4 via @Verge

[Biovista Inc. @BiovistaInc]

Use Biovista Vizit to explore how #Alzheimers is related to #cancer & #periodontitis through #microbiome organisms. https://t.co/1ynpnD0lLq

[Biovista Inc. @BiovistaInc]

Our #Drugrepurposing of a #monoamine #oxidase #inhibitor for #MultipleSclerosis #treatment is up on @figshare #LYD17 https://t.co/afkh2WAx5E

[Andreas Persidis @AndreasPersidis]

"Extreme user profiling: good or bad for search and scientific discovery?" https://t.co/H3Khm035GA by @BiovistaInc on @LinkedIn

[Andreas Persidis @AndreasPersidis]

"You need a hypothesis to drive big data" from the book "Why Small Data Is the New Big Data' https://t.co/lNURXsnyfj

[Biovista Inc. @BiovistaInc]

Biotrend Chemikalien GmbH awards contract to Biovista Inc. for its Vizit literature search tool. #customerengagement https://t.co/t3es771yW0